title: Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients.
authors: Department of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milano marco.montillo@ospedaleniguarda.it.
authors: Marco
authors: M
authors: Montillo
authors: Department of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milano.
authors: Alessandra
authors: A
authors: Tedeschi
authors: Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara.
authors: Gianluca
authors: G
authors: Gaidano
authors: Hematology Division, University of Torino and Center for Experimental Research and Medical Studies, Torino.
authors: Marta
authors: M
authors: Coscia
authors: Oncology and Hematology Unit, General Hospital, Nocera Inferiore, Pavia.
authors: Valeria Belsito
authors: VB
authors: Petrizzi
authors: Department of Oncology-Hematology, Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia.
authors: Ester
authors: E
authors: Orlandi
authors: Hematology Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Milan.
authors: Nicola
authors: N
authors: Cascavilla
authors: Lymphoma Unit, Department of Onco-Hematology, San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milan.
authors: Paolo
authors: P
authors: Ghia
authors: Division of Hematology, Spedali Civili, Brescia.
authors: Marina
authors: M
authors: Motta
authors: Hematology Division, Cuneo Hospital, Milano, Italy.
authors: Andrea
authors: A
authors: Gallamini
authors: Department of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milano.
authors: Anna Maria
authors: AM
authors: Frustaci
authors: Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara.
authors: Davide
authors: D
authors: Rossi
authors: Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara.
authors: Lorenzo
authors: L
authors: De Paoli
authors: Service of Biostatistics, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milano, Italy.
authors: Michele
authors: M
authors: Nichelatti
authors: Department of Oncology/Haematology, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milano.
authors: Enrica
authors: E
authors: Morra
authors: Hematology Division, University of Torino and Center for Experimental Research and Medical Studies, Torino.
authors: Massimo
authors: M
authors: Massaia
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D012008:Recurrence; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018906:Antineoplastic Agents, Alkylating; D004338:Drug Combinations; D009588:Nitrogen Mustard Compounds; D000074323:Alemtuzumab; D000069461:Bendamustine Hydrochloride
keywords: bendamustine; effective treatment; relapsed/refractory chronic lymphocytic leukemia